Chaime Orlev

Chaime Orlev

Finansdirektör/CFO på KAMADA LTD.

Förmögenhet: 95 074 $ per 2026-08-31

56 år
Health Technology
Consumer Services
Transportation

Profil

Chaime Orlev currently works at Kamada Ltd., as Chief Financial Officer from 2017.
Mr. Orlev also formerly worked at ICTS International NV, as Chief Financial Officer & Controller in 2001, Gammacan International, Inc., as Chief Financial Officer in 2008, Chiasma, Inc., as Vice President-Finance & Administration from 2010 to 2016, Bioblast Pharma Ltd., as CFO, VP-Finance & Administration from 2016 to 2017, Huntleigh USA Corp., as Chief Financial Officer & Vice President-Finance in 2004, Oramed Pharmaceuticals, Inc., as Chief Financial Officer in 2009, and Solel Solar Systems Ltd., as Chief Financial Officer in 2005.
Mr. Orlev received his undergraduate degree from The College of Management Academic Studies and Masters Business Admin degree from The Leon Recanati Graduate School of Business Administration.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
KAMADA LTD
0,02 %
2026-04-07 11 633 ( 0,02 % ) 95 074 $ 2026-08-31

Aktiva positioner av Chaime Orlev

FöretagPositionStart
KAMADA LTD. Finansdirektör/CFO 2017-12-31

Tidigare kända positioner av Chaime Orlev

FöretagPositionSlut
Finansdirektör/CFO 2017-11-01
CHIASMA, INC. Finansdirektör/CFO 2015-06-10
ORAMED PHARMACEUTICALS INC. Finansdirektör/CFO 2009-01-01
Finansdirektör/CFO 2008-02-01
Finansdirektör/CFO 2005-09-01
Se detaljerna i Chaime Orlevs erfarenhet

Chaime Orlevs utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

60

Första gradens relationer

10

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag10

Transportation

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Industrial Services

Health Technology

Consumer Services

Consumer Services

  1. Börsen
  2. Insiders
  3. Chaime Orlev
40% rabatt: De bästa verktygen för prenumeranter för att identifiera morgondagens bästa investeringar!
d
:
:
TA DEL AV DET NU